PAVM: PAVmed Inc. Stock

by  •  • Comments Off on PAVM: PAVmed Inc. Stock

SIC 3841 – Surgical and Medical Instruments and Apparatus

Valuation
Market Cap ($M) 23.68
Enterprise Value ($M) 50.38
Book Value ($M) -7.03
Book Value / Share -0.23
Price / Book -3.37
NCAV ($M) -35.53
NCAV / Share -1.14
Price / NCAV -0.67

Profitability (mra)
Return on Invested Capital (ROIC) 1.60
Return on Assets (ROA) 1.07
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.05
Current Ratio 0.06

Balance Sheet (mrq) ($M)
Current Assets 2.16
Assets 30.66
Liabilities 37.69
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 3.00
Operating Income -44.49
Net Income 39.79
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -33.55
Cash from Investing -16.18
Cash from Financing 31.28

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-28 13G Tasso Partners, LLC 18.90
02-13 13G/A Ayrton Capital LLC 9.90 44.10
11-14 13G First Manhattan Co 5.77
09-23 13G Dubreville Anthony Michael 5.50

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-24 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One)
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-28 605 44,886 1.35
2025-04-25 2,792 32,414 8.61
2025-04-24 6,447 79,371 8.12
2025-04-23 12,535 136,924 9.15

(click for more detail)

Similar Companies
NVNO – enVVeno Medical Corporation NXGL – NEXGEL, Inc.
NXL – Nexalin Technology, Inc. PDEX – Pro-Dex, Inc.
PLSE – Pulse Biosciences, Inc.


Financial data and stock pages provided by
Fintel.io